Back to Journals » Clinical Ophthalmology » Volume 4

Unilateral electronegative ERG in a presumed central retinal artery occlusion

Authors Lima , Cella W, Brue' C, Tsang S

Published 17 November 2010 Volume 2010:4 Pages 1311—1314

DOI https://doi.org/10.2147/OPTH.S10374

Review by Single anonymous peer review

Peer reviewer comments 2



Luiz H Lima1, Wener Cella2,4, Claudia Brue5, Stephen H Tsang2.3
1Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil; 2Department of Ophthalmology, 3Bernard and Shirlee Brown Glaucoma Laboratory, Edward S Harkness Eye Institute and Departments of Opthamology, Pathology and Cell Biology, Columbia University, New York, NY, USA; 4Department of Ophthalmology, University of Brasilia, Brasilia, Brazil; 5Department of Opthamology, University Politecnica delle Marche, Ancona, Italy

Abstract: A unilateral electronegative electroretinogram (ERG) was seen in a 94-year-old man with presumed central retinal artery occlusion. Goldmann perimetry revealed central scotoma in the right eye and no abnormalities in the left eye. Full-field ERG in the right eye described a reduction of the b-wave with a relative preservation of the a-wave which is characteristic of electronegative ERG. Hence, our case illustrates that ERG testing is essential for the work-up of individuals with suspected retinal vascular disorders.

Keywords: central retinal artery occlusion, electronegative ERG, inner retina, spectral domain optical coherence tomography

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.